D.E. Shaw & Co
PHAS

D.E. Shaw & Co’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

D.E. Shaw & Co’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,796
Closed -$31K – 4665
2021
Q4 		$31K Sell
11,796
-66,751
-85% -$175K ﹤0.01% 3860
2021
Q3 		$244K Buy
78,547
+60,873
+344% +$189K ﹤0.01% 3168
2021
Q2 		$66K Buy
+17,674
New +$66K ﹤0.01% 3393